Selected as a top priority area in the Institute of Medicine's report "Transforming Health Care Quality," healthcare associated infections (HAIs) contribute to unnecessary morbidity and mortality in hospitalized patients. The Center for Medicare &Medicaid Services no longer reimburses for costs associated with certain HAIs. National organizations have recommended the public reporting of HAI rates by hospitals. For valid and fair HAI comparisons, risk adjustment methods may be required. The organism Clostridium difficile, which causes diarrhea, has become a common microbial threat for patients, probably due to a recently emerged epidemic strain of C. difficile. Antibiotic and gastric acid suppressant therapy and infection control polices are regarded as the main risk factors for C. difficile infection (CDI). Assessing risk factors at the hospital-level enables hospitals to identify their institutional-specific risks. This career development award is being sought by an infectious diseases pharmacist who is currently a tenure-track Assistant Professor. The K08 will provide protected time and mentored research experiences to develop the candidate in the area of health services research, patient safety, and infectious disease epidemiology. She will complete a Ph.D. degree in VCU's Health Administration program with in-depth training in relevant areas such as mixed-method research methodologies, advanced modeling techniques for risk adjustment, and healthcare organization and research. Under the guidance of a highly qualified team of mentors, she is committed to becoming an established, independent researcher who contributes to the evolving field of translating effective strategies for prevention of HAIs into practice and to provide remedies to the challenge of decreasing the occurrence of these infections. Using CDI as a model organism, the research phase will develop strategies to evaluate hospital-level factors associated with increased HAIs among a consortium of large, safety net hospitals. Valid methods for fair risk- adjustment will permit interhospital comparisons of CDI rates, as well as other HAIs. Further, acquiring deeper insights into why hospitals adopt or do not adopt effective CDI prevention practices is valuable to the understanding of the facilitators and barriers to implementation of effective prevention measures.
Specific aims i nclude: (1) To evaluate the extent to which hospital-level antibiotic and gastric acid suppressant usage patterns, infection prevention and control, and pharmacy policies predict on CDI occurrence;(2) To develop and compare various approaches to risk adjustment to identify hospitals with higher (or lower) than expected CDI rates;(3) To identify facilitators and barriers to implementation of best practices for CDI prevention. The research proposed will use a state-of-the-art mixed-method approach including hierarchical models incorporating both patient- and hospital-level data, development of a standardized comparison of CDI rates across hospitals, and a strategy to aid hospitals to identifying priority areas for CDI infection prevention efforts. The methods developed for CDI can then be applied to other HAIs.

Public Health Relevance

Clostridium difficile infection (CDI) is an important cause of healthcare-associated diarrhea and colitis that occurs in hospitalized patients. Providing information to hospitals regarding organizational factors related to CDI risk and a valid inter-hospital comparison of CDI rates can aid hospitals in planning rational interventions to reduce CDI. Subsequently this can reduce CDI-related morbidity and mortality.

Agency
National Institute of Health (NIH)
Institute
Agency for Healthcare Research and Quality (AHRQ)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08HS018578-04
Application #
8414795
Study Section
Health Systems Research (HSR)
Program Officer
Anderson, Kay
Project Start
2010-07-01
Project End
2015-04-30
Budget Start
2013-05-01
Budget End
2014-04-30
Support Year
4
Fiscal Year
2013
Total Cost
Indirect Cost
Name
Virginia Commonwealth University
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
105300446
City
Richmond
State
VA
Country
United States
Zip Code
23298
Pakyz, Amy L; Moczygemba, Leticia R; VanderWielen, Lynn M et al. (2014) Facilitators and barriers to implementing antimicrobial stewardship strategies: Results from a qualitative study. Am J Infect Control 42:S257-63
Pakyz, Amy L; Jawahar, Rachel; Wang, Qin et al. (2014) Medication risk factors associated with healthcare-associated Clostridium difficile infection: a multilevel model case-control study among 64 US academic medical centres. J Antimicrob Chemother 69:1127-31
Motzkus-Feagans, C; Pakyz, A L; Ratliff, S M et al. (2013) Statin use and infections in Veterans with cirrhosis. Aliment Pharmacol Ther 38:611-8
Pakyz, Amy L; Edmond, Michael B (2013) Influence of state laws mandating reporting of healthcare-associated infections: the case of central line-associated bloodstream infections. Infect Control Hosp Epidemiol 34:780-4
Pakyz, Amy L; Lee, Jin A; Ababneh, Mera A et al. (2012) Fluoroquinolone use and fluoroquinolone-resistant Pseudomonas aeruginosa is declining in US academic medical centre hospitals. J Antimicrob Chemother 67:1562-4
Pakyz, Amy; Carroll, Norman V; Harpe, Spencer E et al. (2011) Economic impact of Clostridium difficile infection in a multihospital cohort of academic health centers. Pharmacotherapy 31:546-51